Angiography-Negative Primary Central Nervous System Vasculitis in Children
Arthritis Rheum 52:2159-2167, Benseler, S.M.,et al, 2005
Psychiatric Manifestations of Creutzfeldt-Jakob Disease: A 25-Year Analysis
J Neuropsychiatry Clin Neurosci 17:489-495, Wall,C.A.,et al, 2005
Multiple Actinomycosis Brain Abscesses
Presse Med 33:318-320, Liotier,J.,et al, 2004
Stroke as the First Manifestation of a Concealed Pancreatic Neoplasia
Rev Neurol 38:332-335, Perez-Lazaro,C.,et al, 2004
Mitoxantrone for Multiple Sclerosis in Clinical Practice
Neurol 63(Suppl 6):S25-S27, Rizvi,S.A.,et al, 2004
Natural History of Conservatively Treated Meningiomas
Neurol 63:1133-1134, Herscovici,A.,et al, 2004
The MATCH Study Results in the Context of Secondary Stroke Prevention
Stroke 35:2609, Fisher,M. &Davalos,A., 2004
Early Epidural Blood Patch in Spontaneous Intracranial Hypotension
Neurol 63:1950-1951, Berroir,S.,et al, 2004
Clinicopath Conf, Anaplastic Oligodendroglioma with Allelic Loss of Chromosomes 1p and 19q
NEJM 351:1875-1882, Case 33-2004, 2004
Statins in Stroke Prevention and Carotid Artherosclerosis, Systematic Review and Up-to-Date Meta-Analysis
Stroke 35:2902-2909, Amarenco,P.,et al, 2004
Salvage Therapy for Primary CNS Lymphoma with a Combination of Rituximab and Temozolomide
Neurol 63:901-903, Enting,R.H.,et al, 2004
Thoughts Evoked by MATCH and Other Trials
Stroke 35:2604-2605, Caplan,L.R., 2004
Interferon beta-1b in Secondary Progressive MS
Neurol 63:1779-1787,1768, Kappos,L.,et al, 2004
Interferon beta-1b in Secondary Progressive MS
Neurol 63:1788-1795,1768, The North American Study Group on Interferon beta-, 2004
Lowering Homocysteine in Patients with Ischemic Stroke to Prevent Recurrent Stroke, Myocardial Infarction, and Death
JAMA 291:565-575,621, Toole,J.F.,et al, 2004
Clinical and MRI Outcome after Autologous Hematoipoietic Stem Cell Transplantation in MS
Neurol 62:282-284,168, Saiz,A.,et al, 2004
Blood Pressure and Stroke
Stroke 35:776-785, Lawes,C.M.M.,et al, 2004
Patent Foramen Ovale and Recurrent Stroke: Closure is the Best Option: No
Stroke 35:804-805,806, Tong,D.C. &Becker,K.J., 2004
Patent Foramen Ovale and Recurrent Stroke: Closure is the Best Option: Yes
Stroke 35:803-804,806, Furlan,A.J., 2004
Cognitive Functions in Survivors of Primary Central Nervous System Lymphoma
Neurol 62:548-555,532, Correa,D.D.,et al, 2004
Cognitive Status and Quality of Life After Treatment for Primary CNS Lymphoma
Neurol 62:544-547,532, Harder,H.,et al, 2004
Brain Metastases
The Neurologist 10:31-46, Klos,K.J.&O'Neill,B.P., 2004
Late-Onset Cerebellar Ataxia with Hypogonadism and Muscle Coenzyme Q10 Deficiency
Neurol 62:818-820, Gironi,M.,et al, 2004
Endarterectomy for Symptomatic Carotid Stenosis in Relation to Clinical Subgroups and Timing of Surgery
Lancet 363:915-924, Rothwell,P.M.,et al, 2004
Clinical Spectrum of Episodic Ataxia Type 2
Neurol 62:17-22, Jen,J.,et al, 2004
Favorable Outcome of Ischemic Stroke in Patients Pretreated with Statins
Stroke 35:1117-1123, Marti-Fabregas,J.,et al, 2004
Practice Parameter: Recurrent Stroke with Patent Foramen Ovale and Atrial Septal Aneurysm
Neurol 62:1042-1050, Messe,S.R.,et al, 2004
Stiff-Person Syndrome
The Neurologist 10:131-137, Murinson,B.B., 2004
Long-Term Outcome of Oligodendrogliomas
Neurol 62:1783-1787, Lebrun,C.,et al, 2004
Response of Relapsed or Refractory Primary Central Nervous System Lymphoma (PCNSL) to Topotecan
Neurol 62:1885-1887, Fischer,L.,et al, 2004
Whole Brain Radiation Therapy With or Without Stereotactic Radiosurgery Boost for Patients with One to Three Brain Metastases: Phase III Results of the RTOG 9508 Randomised Trial
Lancet 363:1665-1672, Andrews,D.W.,et al, 2004
Direct Thrombin Inhibition
Stroke 35:1519-1522, Elkind,M.S.V. &Sacco,R.L., 2004
Aspriin and Clopidogrel Compared with Colpidogrel Alone After Recent Ischaemic Stroke or Transient Ischaemic Attack in High-Risk Patients (MATCH): Randomised, Double-Blind, Placebo-Controlled Trial
Lancet 364:331-337, Diener,H.-C.,et al, 2004
Effects of Cholesterol-lowering with Simvastatin on Stroke and Other Major Vascular Events in 20 536 People with Cerebrovascular Disease or Other High-Risk Conditions
Lancet 363:757-767, Heart Protection Study Collaborative Group, 2004
Meningiomas
Lancet 363:1535-1543, Whittle,I.R.,et al, 2004
Prescription of Antithrombotic Therapy in Older Patients Hospitalized for Transient Ischemic Attack and Ischemic Stroke:The GIFA Study
Stroke 35:913-917, Volpato,S.,et al, 2004
Paraneoplastic "Stiff Person Syndrome" with Metastatic Adenocarcinoma and anti-Ri Antibodies
Neurol 62:1402-1404, McCabe,D.J.H.,et al, 2004
Antiplatelet Therapy for Preventing Stroke and Other Vascular Events After Carotid Endarterectomy
Stroke 35:1227-1228, Engelter,S. &Lyrer,P., 2004
Aromatic L-Amino Acid Decarboxylase Deficiency
Neurol 62:1058-1065, Pons,R.,et al, 2004
Alzheimer's Disease
NEJM 351:56-67, Cummings,J.L, 2004
Radiosurgery for Cerebral Arteriovenous Malformations in Hereditary Hemorrhagic Telangiectasia
Neurol 63:367-369, Maarouf,M.,et al, 2004
Chemotherapy as Initial Treatment in Gliomatosis Cerebri
Neurol 63:354-356, Levin,N.,et al, 2004
The Efficacy of Donepezil in the Treatment of Neuropsychiatric Symptoms in Alzheimer Disease
Neurol 63:214-219,200, Holmes,C.,et al, 2004
Initial Chemotherapy in Gliomatosis Cerebri
Neurol 63:270-275,204, Sanson,M.,et al, 2004
Atypical Antipsychotic Drugs in the Treatment of Behavioural and Psychological Symptoms of Dementia: Systematic Review
BMJ 329:75-78, Lee,P.E.,et al, 2004
Reversible Paraneoplastic Neuropathy Associated with T-Cell Large Granular Lymphocyte Leukemia
Neurol 63:588-589, Au,W-Y.,et al, 2004
The Neurological Complications of Bariatric Surgery
Arch Neurol 61:1185-1189, Berger,J.R., 2004
Recommended Diagnostic Criteria for Paraneoplastic Neurological Syndromes
JNNP 75:1135-1140,1090, Graus,F.,et al, 2004
Recent Developments in Thyroid Eye Disease
BMJ 329:385-390, Cawood,T.,et al, 2004
PROTECT A Coordinated Stroke Treatment Program to Prevent Recurrent Thromboembolic Events
Neurol 63:1217-1222, Ovbiagele,B.,et al, 2004